title: Cholesterol embolization to bladder in setting of transient ischemic attack and hematochezia: an unusual presentation of cholesterol embolization syndrome.
authors.affiliation: Department of General Surgery, Marshfield Clinic, Marshfield, Wisconsin, USA.
authors.forename: Carrie E
authors.initials: CE
authors.lastname: Black
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Cold
authors.forename: Darius J
authors.initials: DJ
authors.lastname: Unwala
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D050197:Atherosclerosis / Q000150:complications; D003556:Cystitis / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D003937:Diagnosis, Differential; D017700:Embolism, Cholesterol / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005549:Foreign-Body Reaction / Q000209:etiology; D006471:Gastrointestinal Hemorrhage / Q000209:etiology*; D006099:Granuloma / Q000209:etiology; D006417:Hematuria / Q000209:etiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications; D002546:Ischemic Attack, Transient / Q000209:etiology*; D012307:Risk Factors; D013577:Syndrome; D014401:Tuberculosis, Urogenital / Q000175:diagnosis; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014859:Warfarin